236 related articles for article (PubMed ID: 18829561)
1. Vitamin C antagonizes the cytotoxic effects of antineoplastic drugs.
Heaney ML; Gardner JR; Karasavvas N; Golde DW; Scheinberg DA; Smith EA; O'Connor OA
Cancer Res; 2008 Oct; 68(19):8031-8. PubMed ID: 18829561
[TBL] [Abstract][Full Text] [Related]
2. Protective action of vitamin C against DNA damage induced by selenium-cisplatin conjugate.
Błasiak J; Kowalik J
Acta Biochim Pol; 2001; 48(1):233-40. PubMed ID: 11440175
[TBL] [Abstract][Full Text] [Related]
3. Increased facilitated transport of dehydroascorbic acid without changes in sodium-dependent ascorbate transport in human melanoma cells.
Spielholz C; Golde DW; Houghton AN; Nualart F; Vera JC
Cancer Res; 1997 Jun; 57(12):2529-37. PubMed ID: 9192836
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial ascorbic acid is responsible for enhanced susceptibility of U937 cells to the toxic effects of peroxynitrite.
Guidarelli A; Cerioni L; Fiorani M; Azzolini C; Cantoni O
Biofactors; 2014; 40(2):236-46. PubMed ID: 24105898
[TBL] [Abstract][Full Text] [Related]
5. Activation of mitochondrial oxidation by PDK2 inhibition reverses cisplatin resistance in head and neck cancer.
Roh JL; Park JY; Kim EH; Jang HJ; Kwon M
Cancer Lett; 2016 Feb; 371(1):20-9. PubMed ID: 26607904
[TBL] [Abstract][Full Text] [Related]
6. Sensitivity of K562 and HL-60 cells to edelfosine, an ether lipid drug, correlates with production of reactive oxygen species.
Wagner BA; Buettner GR; Oberley LW; Burns CP
Cancer Res; 1998 Jul; 58(13):2809-16. PubMed ID: 9661895
[TBL] [Abstract][Full Text] [Related]
7. Overcoming multidrug resistance (MDR) in cancer in vitro and in vivo by a quinoline derivative.
Ganguly A; Banerjee K; Chakraborty P; Das S; Sarkar A; Hazra A; Banerjee M; Maity A; Chatterjee M; Mondal NB; Choudhuri SK
Biomed Pharmacother; 2011 Sep; 65(6):387-94. PubMed ID: 21715129
[TBL] [Abstract][Full Text] [Related]
8. Vitamin C enters mitochondria via facilitative glucose transporter 1 (Glut1) and confers mitochondrial protection against oxidative injury.
KC S; Cárcamo JM; Golde DW
FASEB J; 2005 Oct; 19(12):1657-67. PubMed ID: 16195374
[TBL] [Abstract][Full Text] [Related]
9. Dietary curcumin inhibits chemotherapy-induced apoptosis in models of human breast cancer.
Somasundaram S; Edmund NA; Moore DT; Small GW; Shi YY; Orlowski RZ
Cancer Res; 2002 Jul; 62(13):3868-75. PubMed ID: 12097302
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow microenvironment confers imatinib resistance to chronic myelogenous leukemia and oroxylin A reverses the resistance by suppressing Stat3 pathway.
Li X; Miao H; Zhang Y; Li W; Li Z; Zhou Y; Zhao L; Guo Q
Arch Toxicol; 2015 Jan; 89(1):121-36. PubMed ID: 24671465
[TBL] [Abstract][Full Text] [Related]
11. Costunolide induces apoptosis in platinum-resistant human ovarian cancer cells by generating reactive oxygen species.
Yang YI; Kim JH; Lee KT; Choi JH
Gynecol Oncol; 2011 Dec; 123(3):588-96. PubMed ID: 21945308
[TBL] [Abstract][Full Text] [Related]
12. Enhanced therapeutic effects on the multi-drug resistant human leukemia cells in vitro and xenograft in mice using the stealthy liposomal vincristine plus quinacrine.
Liang GW; Lu WL; Wu JW; Zhao JH; Hong HY; Long C; Li T; Zhang YT; Zhang H; Wang JC; Zhang X; Zhang Q
Fundam Clin Pharmacol; 2008 Aug; 22(4):429-37. PubMed ID: 18705753
[TBL] [Abstract][Full Text] [Related]
13. Vitamin C enhances chemosensitization of esophageal cancer cells in vitro.
Abdel-Latif MM; Raouf AA; Sabra K; Kelleher D; Reynolds JV
J Chemother; 2005 Oct; 17(5):539-49. PubMed ID: 16323444
[TBL] [Abstract][Full Text] [Related]
14. Proton pump inhibitors induce apoptosis of human B-cell tumors through a caspase-independent mechanism involving reactive oxygen species.
De Milito A; Iessi E; Logozzi M; Lozupone F; Spada M; Marino ML; Federici C; Perdicchio M; Matarrese P; Lugini L; Nilsson A; Fais S
Cancer Res; 2007 Jun; 67(11):5408-17. PubMed ID: 17545622
[TBL] [Abstract][Full Text] [Related]
15. Development of targeting lonidamine liposomes that circumvent drug-resistant cancer by acting on mitochondrial signaling pathways.
Li N; Zhang CX; Wang XX; Zhang L; Ma X; Zhou J; Ju RJ; Li XY; Zhao WY; Lu WL
Biomaterials; 2013 Apr; 34(13):3366-80. PubMed ID: 23410681
[TBL] [Abstract][Full Text] [Related]
16. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
[TBL] [Abstract][Full Text] [Related]
17. Stromal cell oxidation: a mechanism by which tumors obtain vitamin C.
Agus DB; Vera JC; Golde DW
Cancer Res; 1999 Sep; 59(18):4555-8. PubMed ID: 10493506
[TBL] [Abstract][Full Text] [Related]
18. Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts.
Gourdeau H; Genne P; Kadhim S; Bibeau L; Duchamp O; Ouellet F; deMuys JM; Bouffard DY; Attardo G
Cancer Chemother Pharmacol; 2002 Dec; 50(6):490-6. PubMed ID: 12451476
[TBL] [Abstract][Full Text] [Related]
19. Caspase-8 dependent TRAIL-induced apoptosis in cancer cell lines is inhibited by vitamin C and catalase.
Perez-Cruz I; Cárcamo JM; Golde DW
Apoptosis; 2007 Jan; 12(1):225-34. PubMed ID: 17031493
[TBL] [Abstract][Full Text] [Related]
20. Protective effects of vitamin c against cisplatin-induced nephrotoxicity and lipid peroxidation in adult rats: a dose-dependent study.
Antunes LM; Darin JD; Bianchi MD
Pharmacol Res; 2000 Apr; 41(4):405-11. PubMed ID: 10704263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
